Cargando…
Guidance production before evidence generation for critical issues: the example of COVID-19
Production of guidance in rapidly evolving areas where evidence is absent or fragile is challenging and needs to use rigorous methods interpreted with caution https://bit.ly/3jpChqk
Autores principales: | Roche, Nicolas, Tonia, Thomy, Bush, Andrew, Brightling, Chris, Kolb, Martin, Dinh-Xuan, Anh Tuan, Humbert, Marc, Simonds, Anita, Adir, Yochai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537942/ https://www.ncbi.nlm.nih.gov/pubmed/33020070 http://dx.doi.org/10.1183/16000617.0310-2020 |
Ejemplares similares
-
European Respiratory Society clinical practice guidelines: methodological guidance
por: Nagavci, Blin, et al.
Publicado: (2022) -
COVID-19: guidance on palliative care from a European Respiratory Society international task force
por: Janssen, Daisy J.A., et al.
Publicado: (2020) -
COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence
por: Adir, Yochai, et al.
Publicado: (2021) -
Association between sex and SARS-CoV-2 infection and hospitalisation as a result of COVID-19
por: Adir, Yochai, et al.
Publicado: (2021) -
Rare pulmonary disease and orphan drugs: a path to the future
por: Harari, Sergio, et al.
Publicado: (2019)